Study Reveals Women Face Longer Delays in Autoimmune Diagnosis
A recent study highlights significant delays in accurate autoimmune disease diagnoses for women compared to men.
Women often wait longer for autoimmune disease diagnoses, with nearly 32% experiencing delays of four years or more.
Misdiagnosis rates are higher for women, particularly with mental health issues, affecting their treatment journey.
The study emphasizes the need for healthcare providers to recognize and address these disparities in diagnosis.
A new international study has revealed that women diagnosed with autoimmune diseases frequently encounter longer wait times for accurate diagnoses compared to their male counterparts. Published in eClinicalMedicine, the research underscores the challenges that women face in the healthcare system, particularly in relation to autoimmune conditions, which affect approximately 4.6% of the U.S. population. Despite women being nearly twice as likely to be diagnosed with autoimmune diseases, they often experience significant delays in receiving appropriate care.
The study involved an online survey conducted between December 2024 and March 2025, targeting adults aged 18 and older with confirmed autoimmune or rheumatic diseases. Researchers designed the survey with input from patients and medical experts to ensure it captured critical information regarding the diagnostic journeys of participants. The survey asked respondents about the duration from the onset of symptoms to diagnosis, the number of healthcare visits prior to receiving a diagnosis, and whether their symptoms were misattributed to mental health issues or other conditions.
Out of 6,607 participants, a striking 91.2% identified as female, with the majority residing in the United Kingdom. The findings indicated that nearly 32% of women experienced delays of four years or more before receiving a diagnosis, in contrast to approximately 26% of men. Furthermore, women reported making more visits to healthcare providers, with 26.2% having 11 or more visits compared to 18.4% of men. Misdiagnosis was also prevalent, with 43.3% of women indicating their symptoms were mistaken for mental health issues, compared to 32.7% of men.
The type of autoimmune disease significantly influenced misdiagnosis rates. Conditions with clear physical symptoms, such as type 1 diabetes, had lower misdiagnosis rates compared to diseases like autoimmune encephalitis, where over 50% of women reported misattributions to mental health. The study also found that factors such as geographic location, income level, and specific disease types contributed to the likelihood of misdiagnosis, while age did not appear to be a significant factor.
These findings highlight the urgent need for healthcare providers to recognize the unique challenges faced by women in the diagnostic process for autoimmune diseases. Misdiagnoses can lead to delays in treatment, exacerbating symptoms and increasing frustration among patients. Experts recommend that women advocate for themselves, maintain detailed records of their symptoms, and seek second opinions if necessary to ensure they receive appropriate care.
As awareness of these disparities grows, healthcare professionals are encouraged to adopt a more nuanced approach when evaluating symptoms in female patients, particularly those presenting with complex or vague symptoms. The study calls for a reevaluation of diagnostic practices to improve outcomes for women suffering from autoimmune diseases.
